Morgan Keegan Maintains Outperform on Trustmark (TRMK)
Morgan Keegan is out with its report today on Trustmark (NASDAQ: TRMK), maintaining Outperform.
In a note to clients, Morgan Keegan writes, "We would be buyers of TRMK at current levels as first quarter results reaffirm our view, that led by a top quality and conservative management team, this franchise is well positioned to deploy its excess capital toward pursuing organic as well as M&A opportunities over the coming months/quarters."
Morgan Keegan has a $27 PT on TRMK.
At the time of posting, shares of TRMK were at $23.55, up 0.77% from Tuesday's close.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.